Janney Montgomery Scott
LXRX icon

Janney Montgomery Scott’s Lexicon Pharmaceuticals LXRX Stock Holding History

Janney Montgomery Scott’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$709K Buy
+295,548
New +$576K ﹤0.01% 2145

Other funds holding LXRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CLOS
Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
SOW
State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return
CIP
Cornerstone Investment Partners Atlanta, Georgia $2.99B AUM 60.05% 1-Year Est. Return

Janney Montgomery Scott's LXRX Position: Q2 2026 in Review

Janney Montgomery Scott opened a new position in Lexicon Pharmaceuticals (LXRX) in Q2 2026: 295,548 shares worth $709K. The stake represents ﹤0.01% of the portfolio and ranks #2145 among its holdings.

51 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.

  • Janney Montgomery Scott held 295,548 shares of Lexicon Pharmaceuticals worth $709K as of Q2 2026.
  • Lexicon Pharmaceuticals was a new Janney Montgomery Scott position in Q2 2026.
  • Lexicon Pharmaceuticals made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q2 2026, its #2145 holding.
  • 51 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.

Based on Janney Montgomery Scott's 13F filing for Q2 2026, filed 5 Aug 2026.